CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2 Study of Neoadjuvant Cabozantinib in Combination With Radiation Therapy for Sarcomas of the Extremities

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04220229
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:34.773464+00:00
Published At: 2025-07-17T00:00:00+00:00
Record Updated At: 2025-07-17
Results Posted At: 2025-07-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Sarcoma of the Extremity", "Stage I Soft Tissue Sarcoma of the Trunk and Extremities", "Stage IA Soft Tissue Sarcoma of the Trunk and Extremities", "Stage IB Soft Tissue Sarcoma of the Trunk and Extremities", "Stage II Soft Tissue Sarcoma of the Trunk and Extremities"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-07-17"
protocolSection.identificationModule.nctId: "NCT04220229"
protocolSection.identificationModule.officialTitle: "A Phase 1/2 Study of Neoadjuvant Cabozantinib in Combination With Radiation Therapy for Sarcomas of the Extremities"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-07-17"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.